scholarly journals High circulating elafin levels are associated with Crohn’s disease-associated intestinal strictures

2019 ◽  
Author(s):  
Jiani Wang ◽  
Christina Ortiz ◽  
Lindsey Fontenot ◽  
Ying Xie ◽  
Wendy Ho ◽  
...  

AbstractObjectiveNearly 33% of Crohn’s disease (CD) patients develop intestinal strictures. Antimicrobial peptide or protein expression is associated with disease activity in inflammatory bowel disease (IBD) patients. Circulating blood cells and intestine of IBD patients have abnormal expression of elafin, a human elastase-specific protease inhibitor and antimicrobial peptide. However, the association between elafin and CD-associated intestinal stricture is unknown. We hypothesize the elafin expression in stricturing CD patients is abnormal. We determined the expression of elafin in blood, intestine, and mesenteric fat in IBD patients.MethodsHuman colonic and mesenteric fat tissues and serum samples were collected from the Cedars-Sinai Medical Center and UCLA, respectively.ResultsHigh serum elafin levels were associated with a significantly elevated risk of intestinal stricture in CD patients. Machine learning algorithm using serum elafin levels and clinical data identified stricturing CD patients with high accuracy. Serum elafin levels had weak positive correlation with clinical disease activity (Partial Mayo Score and Harvey Bradshaw Index) in IBD patients. Ulcerative colitis (UC) patients had high serum elafin levels, but the increase was not associated with endoscopic Mayo score. Colonic elafin mRNA and protein expression were not associated with clinical disease activity in IBD patients, while stricturing CD patients had low colonic elafin expression. Mesenteric fat in stricturing CD patients had significantly increased elafin mRNA expression, which may contribute to high circulating elafin level.ConclusionHigh serum elafin levels and adipose elafin expression are associated with intestinal strictures, which may help identify intestinal strictures in CD patients.


2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Elizabeth A. Scoville ◽  
Margaret M. Allaman ◽  
Dawn W. Adams ◽  
Amy K. Motley ◽  
Shannon C. Peyton ◽  
...  


2016 ◽  
Vol 8 (5) ◽  
pp. 614-621 ◽  
Author(s):  
Holger Schäffler ◽  
Daniel P. R. Herlemann ◽  
Christian Alberts ◽  
Annika Kaschitzki ◽  
Peggy Bodammer ◽  
...  




2018 ◽  
Vol 27 (4) ◽  
pp. 391-397 ◽  
Author(s):  
Akos Ilias ◽  
Barbara D Lovasz ◽  
Lorant Gonczi ◽  
Zsuzsanna Kurti ◽  
Zsuzsanna Vegh ◽  
...  

Background & Aims: Rapid optimization of treatment algorithms and disease outcomes requires an objective measurement of disease activity in patients with Crohn’s disease (CD). Our aim was to evaluate the impact of rapid-access to magnetic resonance imaging (MRI) on treatment optimization, clinical decision-making and outcomes for CD patients in a specialized tertiary care for inflammatory bowel disease (IBD) patients.Methods: A cohort of 75 referral CD patients (median age: 34, IQR: 25-43 years) who had underwent 90 fasttrack MR enterography (MRE) scans between January 2014 and June 2016 were retrospectively enrolled. The MRI results were compared to clinical activity scores and biomarkers (C-reactive protein). The immediate impact of fast-track MRI on clinical decision-making, including changes in medical therapy, the need of hospitalization and surgery were evaluated.Results: The location of CD was ileo-colonic in 61% of the patients with perianal fistulas in 56% and previous surgeries in 55%. The indication for fast-track MRI scans was active disease (clinical or biomarker activity) in 55.6%. The radiological activity (including mild radiological signs to severe lesions) was detected in 94% of cases. Significant/severe MRI activity was depicted in 68% of these patients. Correlation between MRI radiological activity and clinical disease activity or colonoscopy was moderate (kappa: 0.609 and 0.652). A change in therapeutic strategy was made in 94.1% of cases with severe MRI radiological activity vs. 50% of patients without severe MRI radiological activity (p=0.001). Significant/severe MRI activity was followed by higher surgery rates among patients with clinical disease activity (50% vs. 12.5%; p=0.013). MRI performed on patients with clinical and biomarker remission identified disease activity in a significantly smaller proportion.Conclusions: Fast-track MRI had a great impact on patient management in CD patients with clinical or biomarker activity, leading to better patient stratification and faster optimization of the therapy (medical or surgical), while MRI revealed previously undiagnosed disease activity only in a small proportion of patients in clinical remission.



2017 ◽  
Vol 152 (5) ◽  
pp. S761-S762
Author(s):  
Elizabeth A. Scoville ◽  
Dawn W. Adams ◽  
Margaret M. Allaman ◽  
Amy Motley ◽  
Shannon C. Peyton ◽  
...  


Gut ◽  
2013 ◽  
Vol 63 (1) ◽  
pp. 88-95 ◽  
Author(s):  
Laurent Peyrin-Biroulet ◽  
Walter Reinisch ◽  
Jean-Frederic Colombel ◽  
Gerassimos J Mantzaris ◽  
Asher Kornbluth ◽  
...  




2002 ◽  
Vol 179 (4) ◽  
pp. 1029-1036 ◽  
Author(s):  
Seung Soo Lee ◽  
Hyun Kwon Ha ◽  
Suk-Kyun Yang ◽  
Ah Young Kim ◽  
Tae Kyoung Kim ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document